Ambicare Health

Ambicare Health is a spin-out company from NHS Tayside, SHIL and the University of St Andrews.

Founded in 2004, Ambicare has made substantial progress in the development and commercialisation of proprietary, wearable LED-based devices for treating a range of skin conditions and diseases. The company has developed two distinct, clinically proven product lines for the treatment of specific dermatological conditions: non-melanoma skin cancer and acne.

The patented platform technology allows the patient to wear the light delivery device in daily use, enhancing convenience to the user and delivering improved end results through consistency of light delivery to the skin.

Their acne product, Lustre Pure LightTM has obtained FDA clearance to be sold OTC in the US.

Aridhia

Aridhia was founded in 2007 as a spin-out company from SHIL.

AnalytiXagility, the company’s cloud-based data analysis platform, is a secure, self-service platform built to enhance the way researchers in biomedical research, precision medicine and healthcare environments access and analyse data.

AnalytiXagility brings the economic and adoption benefits of 3rd generation consumer technologies to research, accelerating data and analytical processes in a secure and reproducible way, and supporting trusted data sharing within a secure, audited and transparent environment.

Today, AnalytiXagility is used by ground-breaking research organisations around the world to enable the execution of collaborative research projects and business models including pre-competitive drug trials, multi-institutional data-driven precision medicine initiatives, and integrated healthcare programmes.

Aurum Biosciences

Clear Surgical

Clear Surgical was set up in 2013 as a spin-out from SHIL.

A medical device company, the team develop innovative solutions to surgical problems. Products include the only disposable, self-retaining illuminated retractor for improving the field of light in surgical cavities and the cannulated reduction forceps that act as a universal guidance system for use in treating fractures for orthopaedic patients.

Touch Bionics

Touch Bionics began as an idea from NHS Lothian and became the first SHIL spin-out in 2002.

Originally called Touch EMAS (Edinburgh Modular Arm System), in 2005 it was re-branded Touch Bionics to communicate the dynamism of the company’s products and the future focus on its prosthesis technology: bionics in medicine being the replacement or enhancement of organs or other body parts by mechanical means.

An initial SMART award from Scottish Enterprise started the company, and it has since received funding from existing and new investors including Archangel Informal Investments, TriCAP, Clydesdale Bank and the Scottish Co-investment Fund.

On 11 April 2016 Touch Bionics was acquired by Össur, a recognised "Technology Pioneer" and global leader in non-invasive orthopaedics that help people live a life without limitations, in a sale worth £27.5m.